Crossref
CON: Patients With Recurrent Ovarian Carcinoma Should Not be Treated With Antiangiogenic Agents in Combination With Chemotherapy
Clinical Ovarian Cancer · 2011
DOI: 10.1016/j.cloc.2012.02.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Ovarian Cancer, 2011. Verfasst von Paul Sabbatini. Die Arbeit nennt 20 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sabbatini, P. (2011). CON: Patients With Recurrent Ovarian Carcinoma Should Not be Treated With Antiangiogenic Agents in Combination With Chemotherapy. Clinical Ovarian Cancer. https://doi.org/10.1016/j.cloc.2012.02.009
Vancouver
Sabbatini P. CON: Patients With Recurrent Ovarian Carcinoma Should Not be Treated With Antiangiogenic Agents in Combination With Chemotherapy. Clinical Ovarian Cancer. 2011. doi:10.1016/j.cloc.2012.02.009
BibTeX
@article{Sabbatini2011,
author = {Sabbatini, Paul},
title = {CON: Patients With Recurrent Ovarian Carcinoma Should Not be Treated With Antiangiogenic Agents in Combination With Chemotherapy},
journal = {Clinical Ovarian Cancer},
year = {2011},
doi = {10.1016/j.cloc.2012.02.009}
}
EUVIMED